PSYCHEDELIC DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)
Segmentation
By Drug TypeGamma Hydroxybutyric Acid · Ketamine · Psilocybin · Lysergic Acid Diethylamide · 3 · 4-Methylenedioxymethamphetamine · and Other Drug Types
By ApplicationMental Health Disorders · Neurological Disorders · Pain Management · and Other Applications
By Distribution ChannelHospital Pharmacy · Retail Pharmacy · and Online Pharmacy
By Route of administrationOral · Intravenous · Inhalation · Intranasal · and Others
By GeographyNorth America · Latin America · Asia Pacific · Europe · Middle East · and Africa
Published In30 Mar 2026
Report CodeCMI7527
Pages250+
FormatsExcel and PDF
Base Year2025
Estimated Year2026
Historical Range2020 - 2024
Forecast Period2026-2033
Market Segmentation
By Drug Type Insights (Revenue, USD Bn, 2021 - 2033)
Gamma Hydroxybutyric Acid (GHB)
Ketamine
Psilocybin
Lysergic Acid Diethylamide (LSD)
3,4-Methylenedioxymethamphetamine (MDMA)
Other Drug Types (Mescaline, etc.)
By Application Insights (Revenue, USD Bn, 2021 - 2033)
Mental Health Disorders
Depression
Anxiety
PTSD (Post-Traumatic Stress Disorder)
Substance Use Disorders
Neurological Disorders
Alzheimer’s Disease
Parkinson’s Disease
Pain Management:
Chronic Pain
Migraines
Other Applications:
Obsessive-Compulsive Disorder (OCD)
Others (Opiate Addiction, etc.)
By Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)